SignatureFD’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.98K Buy
276
+102
+59% +$2.24K ﹤0.01% 2769
2026
Q1
$3.87K Buy
174
+82
+89% +$1.96K ﹤0.01% 2865
2025
Q4
$2.46K Hold
92
﹤0.01% 2915
2025
Q3
$1.96K Buy
92
+11
+14% +$260 ﹤0.01% 2956
2025
Q2
$1.75K Buy
+81
New +$1.51K ﹤0.01% 2903
2025
Q1
Sell
-41
Closed -$752 3322
2024
Q4
$752 Sell
41
-363
-90% -$5.86K ﹤0.01% 3080
2024
Q3
$6.21K Hold
404
﹤0.01% 2505
2024
Q2
$6.57K Buy
404
+381
+1,657% +$6.15K ﹤0.01% 2422
2024
Q1
$425 Sell
23
-27
-54% -$669 ﹤0.01% 3043
2023
Q4
$1.57K Buy
50
+8
+19% +$191 ﹤0.01% 2825
2023
Q3
$875 Hold
42
﹤0.01% 2953
2023
Q2
$1.01K Buy
+42
New +$934 ﹤0.01% 2973
2022
Q4
Sell
-20
Closed 3279
2022
Q3
$0 Sell
20
-69
-78% -$1.12K ﹤0.01% 3088
2022
Q2
$1K Sell
89
-3
-3% -$56 ﹤0.01% 2860
2022
Q1
$2K Sell
92
-8
-8% -$194 ﹤0.01% 2757
2021
Q4
$2K Buy
+100
New +$2.01K ﹤0.01% 2659
2021
Q3
Sell
-420
Closed -$10K 3015
2021
Q2
$10K Buy
420
+266
+173% +$6K ﹤0.01% 1964
2021
Q1
$4K Buy
154
+98
+175% +$4.31K ﹤0.01% 2197
2020
Q4
$3K Buy
+56
New +$2.78K ﹤0.01% 2095
2020
Q3
Sell
-42
Closed -$2K 2581
2020
Q2
$2K Buy
+42
New +$2.02K ﹤0.01% 2065

Other funds holding ACAD

SignatureFD's ACAD Position: Q2 2026 in Review

SignatureFD increased its Acadia Pharmaceuticals (ACAD) stake by 59% in Q2 2026, buying an estimated $2.24K and bringing the position to 276 shares worth $6.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

SignatureFD first reported a position in ACAD in Q2 2020 and has held it in 20 quarters since. The position peaked at $10K in Q2 2021. 53 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • SignatureFD held 276 shares of Acadia Pharmaceuticals worth $6.98K as of Q2 2026.
  • SignatureFD bought 102 Acadia Pharmaceuticals shares in Q2 2026, an estimated $2.24K.
  • Acadia Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2769 holding.
  • SignatureFD first reported a position in Acadia Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
  • SignatureFD's Acadia Pharmaceuticals position peaked at $10K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.